ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of ARMO BioSciences, Inc.

NEW YORK, May 10, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against ARMO BioSciences, Inc. (NASDAQ: ARMO) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Eli Lilly and Company. Stockholders will receive $50.00 for each share of ARMO BioSciences stock that they hold. The transaction is valued at approximately $1.6 billion and is expected to close by the end of the second quarter of 2018.

If you are a stockholder of ARMO BioSciences, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/armo. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. 

Attorney Advertising. Prior results do not guarantee a similar outcome.

SOURCE Rowley Law PLLC

Related Links

http://rowleylawpllc.com